European Heart Journal · 2017 · 703 citations · 38 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyVascular SurgeryAortic StenosisAortic Valve DiseaseCardiac Valve SurgeryMitral Valve DiseaseSurgical Valve ReplacementValvular Heart DiseaseAortic Stenosis AssessmentAortic Valve Disease PrognosisAortic Valve EvaluationEchocardiographic HemodynamicsEchocardiographic QuantificationEchocardiographic Severity AssessmentHemodynamic Severity GradingKaplan-meier Survival Estimates
AIMS: In patients with aortic stenosis (AS), risk stratification for aortic valve replacement (AVR) relies mainly on valve-related factors, symptoms and co-morbidities. We sought to evaluate the prognostic impact of a newly-defined staging classification characterizing the extent of extravalvular (extra-aortic valve) cardiac damage among patients with severe AS undergoing AVR. METHODS AND RESULTS: Patients with severe AS from the PARTNER 2 trials were pooled and classified according to the presence or absence of cardiac damage as detected by echocardiography prior to AVR: no extravalvular cardiac damage (Stage 0), left ventricular damage (Stage 1), left atrial or mitral valve damage (Stage 2), pulmonary vasculature or tricuspid valve damage (Stage 3), or right ventricular damage (Stage 4). One-year outcomes were compared using Kaplan-Meier techniques and multivariable Cox proportional hazards models were used to identify 1-year predictors of mortality. In 1661 patients with sufficient echocardiographic data to allow staging, 47 (2.8%) patients were classified as Stage 0, 212 (12.8%) as Stage 1, 844 (50.8%) as Stage 2, 413 (24.9%) as Stage 3, and 145 (8.7%) as Stage 4. One-year mortality was 4.4% in Stage 0, 9.2% in Stage 1, 14.4% in Stage 2, 21.3% in Stage 3, and 24.5% in Stage 4 (Ptrend < 0.0001). The extent of cardiac damage was independently associated with increased mortality after AVR (HR 1.46 per each increment in stage, 95% confidence interval 1.27-1.67, P < 0.0001). CONCLUSION: This newly described staging classification objectively characterizes the extent of cardiac damage associated with AS and has important prognostic implications for clinical outcomes after AVR.
38
Roberto M. Lang, Luigi P. Badano, Victor Mor‐Avi et al. · Journal of the American Society of Echocardiography · 2015 · 18K citations · Full text
Sherif F. Nagueh, Otto A. Smiseth, Christopher P. Appleton et al. · Journal of the American Society of Echocardiography · 2016 · 6.7K citations · Full text
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
Martin B. Leon, Craig R. Smith, Michael J. Mack et al. · New England Journal of Medicine · 2016 · 5K citations · Full text
Medicine, Cardiology, Surgery +13
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian, Ottavio Alfieri, Felicita Andreotti et al. · European Heart Journal · 2012 · 3.6K citations · Full text
Medicine, Cardiology, Surgery +14